Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Mark Wener and Anna Wald.
Mark Wener
Connection Strength
0.289
Anna Wald
  1. Self-collection of capillary blood using Tasso-SST devices for Anti-SARS-CoV-2 IgG antibody testing. PLoS One. 2021; 16(9):e0255841.
    View in: PubMed
    Score: 0.060
  2. Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial. EClinicalMedicine. 2021 Mar; 33:100773.
    View in: PubMed
    Score: 0.058
  3. Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates. J Clin Invest. 2021 02 01; 131(3).
    View in: PubMed
    Score: 0.058
  4. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial. Ann Intern Med. 2021 03; 174(3):344-352.
    View in: PubMed
    Score: 0.057
  5. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 03; 21(1):475.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.